期刊文献+

Over-expression of Sox4 and β-catenin Is Associated with a Less Favorable Prognosis of Osteosarcoma

Over-expression of Sox4 and β-catenin Is Associated with a Less Favorable Prognosis of Osteosarcoma
下载PDF
导出
摘要 The purpose of this study was to examine the association of the expression of Sox4 and β-catenin with the prognosis of osteosarcoma. A total of 108 cases of conventional osteosarcoma were involved in this study and 28 cases of osteochondroma served as controls. The expression of Sox4 and β-catenin was detected by using immunohistochemical staining and Western blotting. The results showed that Sox4 and β-catenin were over-expressed in 67(62.03%) and 62(57.41%) of 108 osteosarcoma cases, while in only 3(10.71%) and 5(17.86%) of 28 controls, respectively(P〈0.05 for all). The expression of Sox4 and β-catenin was associated with the distant metastasis, pathological grade and Enneking stage of patients with osteosarcoma(P〈0.05 for all). The mean overall survival time and the 5-year-survival rate in osteosarcoma patients with Sox4 and β-catenin over-expressed were significantly reduced as compared with those in Sox4 and β-catenin low-expression group(P〈0.05 for all). Cox multifactor regression analysis revealed that the distant metastasis, Enneking stage, and the expression of Sox4 and β-catenin were independent risk factors of patients with osteosarcoma(P〈0.05 for all). The findings indicated that overexpression of Sox4 and β-catenin is associated with a poor prognosis of osteosarcoma. The purpose of this study was to examine the association of the expression of Sox4 and β-catenin with the prognosis of osteosarcoma. A total of 108 cases of conventional osteosarcoma were involved in this study and 28 cases of osteochondroma served as controls. The expression of Sox4 and β-catenin was detected by using immunohistochemical staining and Western blotting. The results showed that Sox4 and β-catenin were over-expressed in 67(62.03%) and 62(57.41%) of 108 osteosarcoma cases, while in only 3(10.71%) and 5(17.86%) of 28 controls, respectively(P〈0.05 for all). The expression of Sox4 and β-catenin was associated with the distant metastasis, pathological grade and Enneking stage of patients with osteosarcoma(P〈0.05 for all). The mean overall survival time and the 5-year-survival rate in osteosarcoma patients with Sox4 and β-catenin over-expressed were significantly reduced as compared with those in Sox4 and β-catenin low-expression group(P〈0.05 for all). Cox multifactor regression analysis revealed that the distant metastasis, Enneking stage, and the expression of Sox4 and β-catenin were independent risk factors of patients with osteosarcoma(P〈0.05 for all). The findings indicated that overexpression of Sox4 and β-catenin is associated with a poor prognosis of osteosarcoma.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2016年第2期193-199,共7页 华中科技大学学报(医学英德文版)
基金 supported by grants from the Natural Science Research Program of Education Bureau of Anhui Province(No.KJ2013B141) Development Funds of Key Projects of Bengbu Medical College(No.Bykf13A13) Natural Science Foundation of Colleges and Universities of Anhui Province(No.KJ2015B083by) Key Natural Science Project of Colleges and Universities of Anhui Province(No.1408085MH147)
关键词 OSTEOSARCOMA OSTEOCHONDROMA Sox4 Β-CATENIN PROGNOSIS osteosarcoma osteochondroma Sox4 β-catenin prognosis
  • 相关文献

参考文献1

二级参考文献5

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部